TPH reports 1st case of West Nile Virus, what’s the cure

eAwazHealth

Toronto – Toronto Public Health (TPH) has reported its first probable human case of West Nile virus (WNV) in an adult resident this year. WNV is an infection transmitted to people through the bite of an infected mosquito. Residents can take the following steps to help protect themselves from WNV: Wearing light-coloured, long-sleeved shirts and pants when outdoors. Applying an …

TPH confirms 1st mosquitos to test positive for West Nile virus in 2024

eAwazHealth

Toronto – Toronto Public Health (TPH) has confirmed that a batch of mosquitoes collected in Toronto have tested positive for West Nile Virus (WNV). These mosquitoes are the first to test positive for WNV – an infection transmitted to people through the bite of an infected mosquito – in Toronto this year.  TPH conducts mosquito surveillance from mid-June to mid-September …

Soliris approved in Japan for paediatric patients

eAwazMedicine

London – Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis (gMG) in paediatric patients who are anti-acetylcholine receptor (AChR) antibody-positive and whose symptoms are difficult to control with high-dose intravenous immunoglobulin (IVIG) therapy or plasmapheresis (PLEX). Soliris is the first and only targeted therapy approved for the treatment of children and adolescents with gMG …

Toronto Public Health confirms 1st mosquitos to test positive for West Nile virus in 2023

eAwazHealth

Toronto – Toronto Public Health (TPH) has received confirmation of one batch of mosquitoes that tested positive for West Nile Virus (WNV). These mosquitoes were collected from a northwest Scarborough location and are the first to test positive for WNV – an infection transmitted to people through the bite of an infected mosquito – in Toronto this year. TPH conducts …

Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder

eAwazMedicine

London – Ultomiris (ravulizumab) has been approved in the European Union (EU) as the first and only long-acting C5 complement inhibitor for the treatment of adult patients with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the …

WARNING TO PUCLIC AFTER INCREASED OVERDOSE INCIDENTS IN MARKHAM

eAwazLocal News

York – Investigators with the York Regional Police #5 District Criminal Investigations Bureau is reminding the community about the life-threatening dangers of fentanyl use after three deaths and one overdose incident that was treated in hospital in the last two days. Between Friday, April 28, 2023, and Saturday, April 29, 2023, officers responded three calls that are related to drug …